Info

ZelleRx Corporation is a biopharmaceutical company developing cancer treatment products based on its proprietary natural killer (NK) cell line, NK-92. The company has a pipeline of universal and targeted products in clinical development against a variety of cancers as adjuvant and primary therapies.